COMPOUNDS FOR PIM KINASE INHIBITION AND FOR TREATING MALIGNANCY

摘要

The present invention relates to the compounds of formula I as well as to their use as PIM kinase inhibitors and, thereby, their use for treating oncological diseases, particularly of the hematopoietic system, the liver and the prostate gland.